Molecular targeted therapy for esophageal cancer
10.11904/j.issn.1002-3070.2015.01.012
- VernacularTitle:食管癌靶向治疗研究进展
- Author:
Zidan QIU
;
Jiancheng LI
- Publication Type:Journal Article
- Keywords:
Esophageal cancer;
Targeted therapy;
Epidermal growth factor receptor;
Vascular endothelial growth factor
- From:
Practical Oncology Journal
2015;(1):57-60
- CountryChina
- Language:Chinese
-
Abstract:
According to the 2012 estimates,esophageal cancer(EC)was the fifth commonly diagnosed cancer and the forth leading cause of cancer -related death .The incidence and mortality rates of EC have been increasing in China .Combined -modality therapy for EC is well accepted , and molecular targeted therapy be-comes a research area.Nowadays,multiple agents have been developed and studied in phase Ⅱ/Ⅲtrials,mainly including cetuximab,erlotinib,trastuzumab,bevacizumab.In this review,we focus on the development of molecular targeted therapy for EC .
